ZKSCAN3 inhibitors belong to a specialized category of chemical compounds that have attracted significant interest in the field of molecular biology and gene regulation research. ZKSCAN3, also known as zinc finger with KRAB and SCAN domains 3, is a transcriptional repressor protein that plays a pivotal role in regulating gene expression. The term ZKSCAN3 inhibitors refers to a group of molecules meticulously designed to selectively target and modulate the activity of ZKSCAN3. These inhibitors serve as invaluable tools in laboratory investigations, enabling researchers to delve into the intricate molecular functions and cellular processes associated with ZKSCAN3.
ZKSCAN3 inhibitors typically function by interacting with the ZKSCAN3 protein or its associated molecules, thereby interfering with its transcriptional repression activities. This interference can lead to the modulation of gene expression patterns and downstream cellular processes influenced by ZKSCAN3, ultimately impacting various aspects of cellular biology. Researchers employ ZKSCAN3 inhibitors to gain insights into the physiological roles and molecular interactions of ZKSCAN3 within cells, aiming to advance our understanding of the fundamental mechanisms involved in gene regulation. Through the study of ZKSCAN3 inhibitors, scientists seek to unravel the complexities of transcriptional control, gene expression, and the broader field of cellular and molecular biology, shedding light on how cells precisely regulate their genetic information and orchestrate various cellular functions.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Spautin-1 | 1262888-28-7 | sc-507306 | 10 mg | $165.00 | ||
Identified as an autophagy inhibitor, which may downregulate ZKSCAN3 as a feedback mechanism due to its role in autophagy. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Known to inhibit autophagy by raising lysosomal pH, potentially reducing ZKSCAN3 expression by disrupting its regulatory pathways. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $56.00 $256.00 | 113 | |
An inhibitor of autophagy that might affect ZKSCAN3 expression by blocking early stages of autophagosome formation. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $96.00 $250.00 $750.00 $1428.00 | 280 | |
A known autophagy inhibitor that may alter ZKSCAN3 expression due to its role in lysosomal dysfunction. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
By inhibiting PI3K, it impacts autophagy and could lead to reduced ZKSCAN3 expression through feedback mechanisms. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Another PI3K inhibitor, it could affect ZKSCAN3 expression by altering signaling pathways involved in autophagy. | ||||||
Torin 1 | 1222998-36-8 | sc-396760 | 10 mg | $240.00 | 7 | |
An mTOR inhibitor that could indirectly reduce ZKSCAN3 expression by impacting the mTOR autophagy regulatory pathway. | ||||||
hydroxychloroquine | 118-42-3 | sc-507426 | 5 g | $56.00 | 1 | |
Similar to chloroquine, it may affect ZKSCAN3 expression by disrupting lysosomal acidification and autophagy. | ||||||
SAR405 | 1523406-39-4 | sc-507416 | 1 mg | $125.00 | ||
A Vps34 inhibitor that may reduce ZKSCAN3 expression through its role in the regulation of autophagy. | ||||||
SBI-0206965 | 1884220-36-3 | sc-507431 | 10 mg | $122.00 | ||
An ULK1 inhibitor that could affect ZKSCAN3 by inhibiting the initiation of autophagy. | ||||||